The ALG-2/AIP-complex, a modulator at the interface between cell proliferation and cell death? A hypothesis  by Krebs, Joachim & Klemenz, Roman
Review
The ALG-2/AIP-complex, a modulator at the interface between cell
proliferation and cell death? A hypothesis
Joachim Krebs a;*, Roman Klemenz b
a Institute of Biochemistry, Swiss Federal Institute of Technology (ETH), Universitaetsstrasse 16, CH-8092 Zurich, Switzerland
b Department of Pathology, University Hospital, Schmelzbergstrasse 12, CH-8091 Zurich, Switzerland
Received 11 September 2000; accepted 12 September 2000
Abstract
During the development of an organism cell proliferation, differentiation and cell death are tightly balanced, and are
controlled by a number of different regulators. Alterations in this balance are often observed in a variety of human diseases.
The role of Ca2 as one of the key regulators of the cell is discussed with respect to two recently discovered proteins, ALG-2
and AIP, of which the former is a Ca2-binding protein, and the latter is substrate to various kinases. The two proteins
interact with each other in a Ca2-dependent manner, and the role of the complex ALG-2/AIP as a possible modulator at the
interface between cell proliferation and cell death is discussed. ß 2000 Elsevier Science B.V. All rights reserved.
Keywords: Apoptosis ; Programmed cell death; Calcium; ALG-2; AIP; Alix; Xp95; Confocal microscopy; Nuclear envelope breakdown
1. Introduction
Tissue homeostasis is a delicate balance between
cell proliferation, di¡erentiation and cell death. Al-
terations in this balance are often observed in a vari-
ety of human diseases. Especially crucial for a nor-
mal tissue development is the coordination and
controlled balance between cell proliferation and
cell death which implies that signaling occurs be-
tween the cell cycle and the cell death machinery.
Programmed cell death (PCD) or apoptosis, a term
which was coined about 25 years ago [1], is a process
during which cells shrink and dissociate from their
surrounding neighbors, their organelles retain in size,
and in the nucleus chromatin forms dense aggregates
on the nuclear membrane, and after the nuclear en-
velope breakdown undergoes DNA fragmentation.
PCD is an important mechanism during develop-
ment which has emerged in multicellular organisms
to remove unnecessary, damaged or aged cells.
Therefore, abnormal resistance towards apoptosis
combined with an uncontrolled cell proliferation
may lead to autoimmune diseases or cancer, whereas
uncontrolled enhancement of apoptotic processes
could favor chronic pathologies such as neurodegen-
erative diseases (e.g., dementia of the Alzheimer
type) or immune de¢ciencies such as AIDS. On the
other hand, a frequent communication between the
proliferation and death pathways may prevent the
survival and expansion of aberrant cells.
The ability to undergo apoptosis is a property
which most, if not all, animal cells have. The activa-
tion of the intrinsic suicide program can be triggered
by a variety of stimuli including DNA fragmenta-
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tion, growth factor withdrawal, admission of steroid
hormones, and calcium in£ux. In this review we will
concentrate on some aspects of the in£uence of cal-
cium on apoptotic processes as compared to its sig-
naling role during cell proliferation. We will discuss
in more detail the role of the recently described
Ca2-binding protein ALG-2 of the penta-EF hand
family [2] interacting with its receptor protein de-
scribed recently as AIP1 [3] or Alix [4] which are
homologous to Xp95, a Xenopus protein involved
in cell proliferation during oocyte maturation [5].
The ALG-2/AIP complex may thus play a modulat-
ing role at the interface between cell proliferation
and cell death. More general information concerning
a wide variety of di¡erent aspects with respect to cell
survival and cell death could be obtained from a
number of recent reviews and references cited therein
[6^11].
2. The signaling role of calcium
Calcium is one of the most versatile second mes-
sengers involved in cell growth, di¡erentiation, and
also in programmed cell death [6]. It plays its pivotal
role through a speci¢c class of proteins, the so-called
EF-hand type Ca2-binding proteins [12]; (see also
[13^15]), some of which are directly involved in the
control of apoptosis linked processes (see below). In
resting cells, the concentration of intracellular free
Ca2 lies between 50 and 200 nM, whereas the cal-
cium concentration in the extracellular space or in
the reticular system within the cell is between 2 and
5 mM. Small changes of the resulting steep concen-
tration gradient across membranes by releasing Ca2
from intracellular stores or by in£ux of Ca2 from
extracellular media through Ca2 channels can be
used to trigger a variety of di¡erent Ca2-dependent
events including cell proliferation and apoptosis as
discussed in detail below. Therefore calcium homeo-
stasis within the cell is tightly controlled by a number
of calcium-transporting systems [16].
3. To live or to die
How does the cell decide on the molecular level
between the proliferative or the apoptotic pathway?
A number of mutations observed in oncogenes can
drive cells to proliferate caused by overexpression of
genes such as cyclin D1, myc, E1A or E2F1. On the
other hand, deregulation of these genes can also re-
sult in induction of cell death which led to the sug-
gestion of a ‘dual signal model’ [7] proposing that a
proliferation stimulus leads to activation of a death
signal, and that proliferation can only occur if the
apoptotic program is suppressed.
A variety of di¡erent stimuli can induce apoptosis
in thymocytes. These include Q-irradiation, stimula-
tion by antibodies against Fas/CD95 antigen [17] and
removal of growth factors from the culture medium
[18]. Most of these stimuli have in common the rise
of intracellular calcium subsequent to the induction
of PCD. Several laboratories provided compelling
evidence that such a rise of intracellular Ca2, com-
mon to cell proliferation and cell death, was linked
to IP3-dependent calcium stores [19^22], indicating
that IP3-dependent Ca2 release is essential, whether
stimulation leads to proliferation or apoptosis, but
what determines the switch in either direction is
probably regulated by other signals.
In a recent study by D’Adamio and his colleagues
attention was focused to identify existing links be-
tween the role of the apoptotic protease caspase-3,
a homologue of ced-3 from C. elegans [23], and the
recently discovered apoptotic linked genes ALG-2
and ALG-3 [24,25]. These authors made the interest-
ing observation that T-cell hybridomas depleted of
ALG-2, a Ca2-binding protein of the EF-hand
type family [25], were protected against PCD induced
by a variety of stimuli including dexamethasone and
Fas/CD95 triggering. The authors provided evidence
that members of the caspase family were activated
upon stimulation by either Fas/APO-1 antibodies
or dexamethasone in ALG-2 depleted cells, but pro-
gression of cell death was impaired indicating that
ALG-2 is necessary for the apoptotic function of
caspases, but is acting downstream of these proteases
[24].
4. ALG-2
The ALG-2 calcium-binding protein was detected
by Vito et al. [25] by using a cDNA library screening
method selecting for genes involved in apoptosis.
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ALG-2 was one of six isolated cDNA clones that
were able to inhibit TCR-induced cell death in a
transient transfection assay. Since ALG-2 was in an
antisense orientation in the expression vector, upon
transfection it produced an ALG-2 antisense RNA in
the transfected cells which reduced the endogenous
ALG-2 protein level in those cells resulting in resis-
tance to TCR-induced cell death [25]. It was also
reported [25] that the ALG-2 dependent pathway
of PCD was dependent on the Ca2-binding property
of ALG-2 since in ¢broblasts overexpressing the full-
length sense ALG-2 cDNA undergo cell death after
applying ionomycin together with PMA, a treatment
which results in an increase of the intracellular Ca2
level and which can cause PCD in T-cells. The same
treatment is ine¡ective if ALG-2 is either expressed
as anti-sense RNA or if an empty plasmid has been
used [25].
ALG-2 is a protein of 191 amino acids in length. It
belongs to the family of intracellular Ca2-binding
proteins carrying the EF-hand motif [13,14]. ALG-
2 contains 5 EF-Hand domains and is related to the
sorcin/grancalcin subfamily of Ca2-binding pro-
teins, the so-called penta-EF-Hand family [2]. The
structure of one of the members of this subfamily,
the small subunit of calpain, has been determined
recently [26,27]. It was described as a dimer in which
the two monomers are paired up with each other
through the ¢fth EF-hand which has lost its Ca2-
binding property due to a two residue insertion [2].
Therefore it was proposed that the other members of
this subfamily showing the penta-EF-hand motif
may also form dimers through the ¢fth EF-hand in
a Ca2-independent manner [2] which could provide
a new interface for the interaction with possible tar-
gets in a similar way as suggested for some of the
S100 proteins [15,28]. The Ca2-independent dimeri-
zation of ALG-2 was recently shown by Lo et al. [29]
who provided evidence that the ¢fth EF-Hand do-
main which is lacking Ca2-binding properties is re-
sponsible for the dimer formation, an observation
based on spectroscopic studies of a number of trun-
cated and point mutants [29]; (see also [4,30]). In
addition, Lo et al. [29] also reported that ALG-2
possesses two high a⁄nity Ca2-binding sites which
upon binding of calcium induce signi¢cant confor-
mational changes in the protein, and which results
in the exposure of a hydrophobic surface as pointed
out by Maki et al. [31], probably important for the
interaction with other proteins (see below).
ALG-2 is a highly conserved protein as evidenced
by a detailed databank analysis [6]. A comparison of
the di¡erent amino acid sequences provided evidence
that ALG-2 from man, mice and rat are almost 100%
identical, whereas the homology to £ies is 80%, and
to nematodes 70% [6]. Of special interest was the
¢nding that all 5 EF-hand motifs were conserved in
all analyzed proteins ^ including the two amino acid
insertion in the ¢fth EF-Hand loop ^ indicating that
ALG-2 must play an important role in Ca2-depen-
dent functions. In addition, it was interesting to note
that the ALG-2 corresponding sequence of the nem-
atode C. elegans (Y110A7.Contig88) lacks the two
amino acids GF in the linker region between EF-
hand 3 and 4 like a recently identi¢ed isoform of
ALG-2 in mice [30] and in human (Krebs, unpub-
lished data). In analyzing the Ca2-binding proper-
ties of the ALG-2 isoform ALG-2.1 Tarabykina et
al. [30] provided evidence that ALG-2.1 di¡ers sig-
ni¢cantly in its Ca2-binding properties from the
wild-type ALG-2.5, that it can heterodimerize with
ALG-2.5, and ^ most importantly ^ that ALG-2.1
does not interact with AIP1/Alix like ALG-2.5.
Recently, Maki et al. [31] studied the intracellular
distribution of ALG-2. These authors reported that
ALG-2 was recovered in the particulate fraction of
COS-cells overexpressing ALG-2, i.e., in the pellet of
a centrifugation at 100 000Ug. It was further deter-
mined that ALG-2 associated in a Ca2-dependent
manner with proteins resistant to extraction with a
bu¡er containing 1% TritonX100 which could indi-
cate cytoskeletal or cytoskeletal-associated proteins.
Those proteins could be even of nuclear origin since
Maki et al. [31] also observed that part of ALG-2
was associated in a Ca2-dependent manner with the
pellet of 600Ug centrifugation. In this context it is
interesting to note that Chen et al. [32] recently de-
scribed the identi¢cation of a cytoskeleton-associated
protein called SETA (SH3 domain-containing pro-
tein expressed in tumorigenic astrocytes) which inter-
acted with the ALG-2/AIP-complex (see below) via
its SH3-domain. Furthermore, Chen et al. [32] also
provided evidence that the interaction between SETA
and the ALG-2/AIP-complex was essential for sensi-
tizing astrocytes to apoptosis.
In collaboration with Dr R. Cadu¡ from the De-
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partment of Pathology of the University Hospital,
Zurich, we recently started a detailed study compar-
ing the expression of ALG-2 between normal and
malignant tissues of human origin. In most of the
cancerous tissues we observed a signi¢cant increase
of ALG-2 expression which was especially evident
for tissues of mamma carcinomas (R. Cadu¡, J.
Krebs, unpublished results). In the course of these
investigations we observed a signi¢cant increase of
ALG-2 expression especially in metastatic tissues of
breast tumors as documented by immunohistochem-
istry using a monoclonal antibody against ALG-2
Fig. 1. Confocal images of MDA cells at di¡erent stages of the cell cycle. Cells have been grown on coverslips, ¢xed with paraformal-
dehyde and incubated either with DAPI (4P-6-diamino-2-phenylindole) (A) or with a monoclonal antibody against ALG-2 (1:50) as
primary antibody and with an anti-mouse antibody labeled with the £uorescent dye Cy-3 (1:100; Jackson Immuno Research, West
Grove, PA) as secondary antibody (B). The merged images of A and B are shown in C. Bar = 8 Wm. The confocal images have been
obtained at the EMZ of the University Zurich with the help of Dr Hoechli, using a Leica Microscope (Wetzlar, Germany), Type DM
IRB E.
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which indicated a nuclear ^ or at least a perinuclear ^
concentration of ALG-2 in those cells (R. Cadu¡, J.
Krebs, unpublished results). These observations led
to a more detailed study of the intracellular distribu-
tion of ALG-2 during mitosis. Using di¡erent cell
lines derived from primary cultures of breast tumors
we indeed observed a signi¢cant nuclear concentra-
tion of ALG-2 in cells prior to cell division using
immuno£uorescence and confocal microscopy as
demonstrated in Fig. 1. However, cells entering the
late prophase characterized by the nuclear envelope
breakdown the presence of ALG-2 in those nuclei
was no longer observable as can be noticed from
Fig. 1 (compare mitotic nuclei in Fig. 1A and B ^
indicated by the arrows ^ in which the DAPI-sensi-
tive nuclear material cannot be co-localized with the
ALG-2 antibodies as in the other intact ^ pro-mitotic
^ nuclei). As typical for many soluble nuclear pro-
teins, e.g., lamin A or C, which are massively re-
leased to the cytoplasm as soon as the nuclear enve-
lope becomes freely permeable at the transition from
mid- to late prophase [33,34] we observed the disap-
pearance of the nuclear localization of ALG-2 at the
onset of cellular division. The reason for this change
in localization of ALG-2 is unclear at the moment,
but could be in£uenced by the complexation of
ALG-2 to its recently described receptor AIP (see
below), by the interaction of the complex with the
nuclear skeleton via an adaptor molecule such as
SETA as mentioned before (see [32]) or by a change
of phosphorylation of AIP as observed for laminA
[35]. Such a possibility will be discussed in detail
below.
5. The AIP1/Alix protein
In 1998 the sequence of a mouse protein of 869
amino acids was deposited in the EMBL databank
by R. Sadoul (accesssion no. AJ005073; see [6]) who
indicated that it interacts with ALG-2. A homology
search in the databank [6] provided evidence that
Alix (ALG-2 interacting protein X) is ^ like ALG-2
^ a highly conserved protein since a human isoform
(AA337670) showed 93% homology, a transcript of
Drosophila melanogaster (AA941497) demonstrated
64% sequence homology, one of Caenorhabditis ele-
gans (U73679) 60% and a homologue in budding
yeast (U37364) still showed 45% homology (BRO1,
see [36]).
Noteworthy were two apparent properties of these
predicted proteins [6] : (1) they all shared a highly
conserved potential recognition site for src-type tyro-
sine-kinases ^ KDNDFIY ^ (see Fig. 2), and (2) they
were proline-rich at the C-terminus with several SH3
Fig. 2. Alignment of the amino acid sequences containing the conserved tyrosine phosphorylation AIP/Alix/Xp95 from di¡erent organ-
isms using the one-letter code. The sequence of the human AIP (hAIP) as determined by the group of K.J. Isselbacher (NP_037506)
was taken as reference to search the di¡erent databases by using BLAST as alignment algorithm [64,65]. The following sequences
have been aligned: mAIP, AIP from mus musculus (NM_011052); xAIP, Xp95 from Xenopus laevis (AF115497; see [5]) ; cAIP,
YNK1-a from Caenorhabditis elegans (U73679); dAIP, homologous sequence from genomic DNA of Drosophila melanogaster
(AE003762); yAIP, homologous sequence of an open reading frame from the genomic DNA of Saccharomyces cerevisiae, chromosome
XV (SCYOR275c; Z75183); sAIP, BRO1 gene of S. cerevisiae, chromosome XVI (U37364; see [36]). Identical residues are written in
capital letters, conserved residues are underlined. The conserved tyrosine residue of the consensus sequence for src-related kinases is
written in bold, capital letters.
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recognition motifs, indicating possible docking sites
for proteins containing SH3-domains.
In 1999, two reports by the groups of D’Adamio
[3] and Sadoul [4] were published describing the iden-
ti¢cation of an ALG-2 interacting protein, calling it
either AIP1 (for ALG-2 interacting protein, [3]) or
Alix [4]. Both groups identi¢ed the same protein in-
teracting with ALG-2 using a yeast two hybrid sys-
tem. Missotten et al. [4] provided evidence not only
that ALG-2 was interacting with itself in a calcium-
independent manner, but also that ALG-2 interacted
with Alix strictly calcium-dependent. Furthermore,
these authors reported that Alix/AIP1 could be co-
immunoprecipitated with ALG-2 from cellular ex-
tracts, in agreement with our results that Alix could
be immunoprecipitated with ALG-2 using a mono-
clonal antibody against ALG-2 (Krebs, unpublished
data). Vito et al. [3] and Missotten et al. [4] reported
that the interaction site for ALG-2 was located in the
C-terminal half of Alix/AIP1. In addition, Vito et al.
[3] provided evidence that ALG-2 and AIP1 colocal-
ize in the cytosol of ¢broblasts, a ¢nding which will
be discussed in more detail below.
In 1999, the group of Kuang reported the identi-
¢cation and characterization of Xp95 from Xenopus
oocytes which turned out to be the Xenopus homo-
logue of Alix/Aip1 [5]. These authors were interested
to study maturation of Xenopus oocytes and to iden-
tify proteins participating in this process, especially
those which are tyrosine phosphorylated during pro-
gesterone-induced maturation of Xenopus oocytes.
Che et al. [5] reported the very interesting ¢nding
that Xp95 was phosphorylated in a progesterone-de-
pendent manner between the ¢rst and second meiotic
division of the Xenopus oocytes, providing evidence
that the tyrosine residue of the conserved KDNDFIY
sequence mentioned before (see Fig. 2) was phos-
phorylated by a src-type kinase. As pointed out by
the authors tyrosine phosphorylation of Xp95 coin-
cided with the phosphorylation time course of MAP-
kinase, but not with the oscillating phosphorylation
of the p34cdc2 kinase indicating that Xp95 phos-
phorylation is associated with progesterone-induced
signal transduction rather than with the induction of
the M-phase [5]. On the other hand, Xp95 was ¢rst
identi¢ed by an a⁄nity-puri¢ed antibody against
cdc25 phosphatase which may indicate that the two
proteins share a common recognition site, and which
could be interpreted that phosphorylated Xp95 could
be dephosphorylated by cdc25 phosphatase. The
cdc25 phosphatase antibodies also recognized the
phosphorylation dependent gel mobility shift like
those raised against YNK1, the C. elegans homo-
logue of Alix/AIP1, providing further evidence that
Xp95 is the Xenopus homologue of the conserved
Alix/AIP1 family [5]. Since, however, AIP/Alix/
Xp95 at the N-terminus share a conserved consensus
sequence ^ KKTS ^ for phosphorylation by PKA or
by other serine/threonine kinases, it is reasonable to
suggest that the tyrosine-phosphorylation time
course of Xp95 recognized by the cdc25 phosphatase
antibody could be signi¢cantly di¡erent from a time-
dependent phosphorylation pattern of that consensus
sequence mentioned before which may re£ect an os-
cillating phosphorylation typical for mitotic kinase
activities. Such a change in phosphorylation of
AIP/Alix/Xp95 during the cell cycle ^ as has been
observed for laminA by p34cdc2 kinase not only
during mitotic, but also during meiotic nuclear enve-
lope breakdown [37] ^ could be responsible for the
described changes in translocation of ALG-2 due to
its interaction with AIP/Alix/Xp95. The veri¢cation
of this proposal clearly has to await further experi-
ments.
6. Cell proliferation and programmed cell death,
two sides of the same coin?
Many early studies on cell cultures indicated that
cells harboring activated oncogenes also exhibited a
signi¢cant amount of cell death. Since then increas-
ing evidence indicated that cell proliferation and cell
death are two intimately linked processes, even if
they appear to be opposing each other and, there-
fore, would be mutually exclusive. On the other
hand, some of the events observed in apoptotic cells
like chromatin condensation and nuclear envelope
breakdown are similar to processes occurring during
mitosis [38]. It has been noted that similar molecular
mechanisms are involved in these two cellular pro-
cesses, especially the activation of p34cdc2 kinase
which is instrumental for the induction of the nuclear
envelope breakdown [39,40]. Essential for the archi-
tecture of the nuclear envelope are the intermediate
¢laments laminA, -B and -C, the major constituents
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of the nuclear lamina [41]. These lamins are phos-
phorylated by p34cdc2 kinase during mitosis which
are a prerequisite for solubilization before nuclear
breakdown and chromatin condensation [35,42,43].
Recently, Neamati et al. [44] reported that glucocor-
ticoid hormones promote laminB degradation in ap-
optotic thymocytes before the onset of DNA frag-
mentation which could be blocked by agents
preventing oligonucleosomal DNA fragmentation in-
cluding protease inhibitors and Ca2 chelators, sug-
gesting that endonuclease activation and lamin deg-
radation are regulated by similar mechanisms. It is
interesting to note that these observation are in good
agreement with those made by Kaiser and Edelman
[45] who demonstrated already more than 20 years
ago that glucocorticoid-stimulated apoptosis of thy-
mocytes was associated with an increase of Ca2 in-
£ux ([45]; see also [46]). Similar to promoting Ca2
increases in apoptotic cells by glucocorticoids such as
dexamethasone, calcium in£ux into cells could also
be associated with di¡erent forms of radiation in-
duced lymphocyte apoptosis which often leads to
DNA fragmentation [47]. Both events activate pro-
tein tyrosine kinases [48,49] which in turn phosphor-
ylates phospholipase CQ thereby activating it [50],
and which subsequently leads to releasing of Ca2
through the Ca2 channel associated with the IP3-
receptor (see [6]). It is interesting to note that appar-
ently those tyrosine kinases have no in£uence on the
activation of p34cdc2 kinase which is activated by
dephosphorylation of their tyrosine residues during
mitosis, since Neamati et al. [44] reported that lamin
degradation in thymocytes stimulated by glucocorti-
coids is independent of tyrosine phosphorylation of
p34cdc2 kinase indicating an important di¡erence in
the sequence of otherwise similar events between cell
proliferation and cell death. These di¡erences could
also become important in this context with respect to
the role of the ALG-2/AIP complex, since it is
known from Lacana et al. [24] that ALG-2 depletion
could protect thymocytes from apoptosis induced by
a variety of stimuli including glucocorticoids as men-
tioned before. This becomes e¡ective downstream of
the activity of proteases such as caspases but up-
stream of DNA fragmentation. These results may
indicate that the ALG-2/AIP complex could play a
critical role in the decision of the cell whether stimuli
may lead to cell proliferation or cell death since this
complex could sensitize changes in various signal
transduction pathways. Those could be dependent
on changes of the intracellular Ca2 concentration
or dependent on the state of phosphorylation/de-
phosphorylation on serine/threonine or on tyrosine
residues, or on both, possibly due to di¡erences in
cellular speci¢city. It will be important to determine
the di¡erent mechanisms underlying those decisions.
7. The role of E2F1
Another interesting aspect concerning the decision
cells have to make with respect to survival or death is
the role of E2F1, a transcription factor able to bind
to the retinoblastoma protein Rb [51^53] which
could play a key role in the cellular consequences
resulting from Rb inactivation (see [54]. In a recent
study by Wang et al. [55] using rapid analysis of gene
expression (RAGE) of mice transgenic for E2F1,
they identi¢ed a number of downstream targets of
E2F1, including Brca1, the gene responsible for
some types of breast cancers. Among the E2F1 tar-
gets Wang et al. [55] also identi¢ed some new targets,
unknown in their function, which they called E2F1-
induced genes (EIG). One of them turned out to be
AIP as demonstrated by a databank analysis (acces-
sion no. AF176514). This EIG-2 gene as named by
Wang et al. [55] was up to 5-fold induced in cells
expressing E2F1 indicating a strong E2F1-dependent
upregulation of AIP. What cellular consequences
could result from an E2F1-dependent expression of
AIP?
E2F activity controls the transcription of genes at
the G1/S-phase transition of the cell cycle including
cyclinE or cdc25 phosphatase [56,57]. By binding to
Rb the transcriptional activation capacity of E2F1 is
inhibited, and converts E2F1 into a transcriptional
repressor. The dissociation of Rb from E2F1, result-
ing in derepression/activation of E2F1 regulated
genes is controlled by the phosphorylation of Rb
by a G1 cyclin kinase such as cyclin D-dependent
cdk [58,59]. Normally, an increase in cyclin D levels
drives cells into the S-phase as a consequence of
extracellular growth factor signals which also pre-
vents apoptosis. However, if the expression of cyclin
D, E2F1 or E1A (which activates E2F1) is uncoupled
from the presence of growth factors, cell cycle entry
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and associated death signaling may occur without
concomitant anti-apoptotic signaling, resulting in
cell death. Recent experiments with mice overex-
pressing E2F1 in di¡erent tissues provided evidence
for the dual role of E2F1 in tumor development, i.e.,
that increased E2F1 activity could either promote or
inhibit tumorigenesis which leads to the paradoxon
that E2F1 could function as both an oncogene and a
tumor suppressor gene (see [54]). These observations
are in line with earlier reports which demonstrated
that most human cancers containing genetic altera-
tions of the cyclinD-Rb pathway result in the dereg-
ulation of E2F-dependent transcription. Thus, the
‘dual-signal’ model as originally proposed by the
group of Evan [38] re£ects the ability of some onco-
genes to promote apoptosis, since pathways control-
ling cell proliferation and apoptosis are coupled.
Therefore, stimulation of cells to enter the cell cycle
drives the cellular apoptotic program, and the pres-
ence of additional survival or pro-apoptotic signals
will determine whether a cell proliferates or is com-
mitting suicide.
Recently, it was reported that oncogenes promot-
ing apoptosis involve the tumor suppressor p19ARF
which interacts with mdm2, preventing its repressive
interaction with p53 [60,61], thereby resulting in
the activation of p53 which could lead either to
growth arrest ^ at G1 or G2 ^ or to apoptosis. Since
the expression of p19ARF is regulated by E2F1
[55,62,63], these results provide compelling evidence
that E2F1 is a key cellular regulator not only for
proliferation, but also for apoptosis as schematically
outlined in Fig. 3. This scheme also includes the pro-
posal of the E2F1 induced AIP as a possible media-
tor between cell proliferation and cell death. Further
experiments are certainly necessary to gain additional
support for the correctness of such a hypothesis.
It thus can be concluded that cell proliferation and
cell death are intimately linked processes which are
under the control of a number of key regulators such
as E2F1. The ALG-2/AIP complex may be an im-
portant modulator involved in the cellular decision
between cell proliferation and cell death. It is ob-
vious that a deregulation of such a delicate balance
could lead to pathological developments such as can-
cer.
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